Dicerna Pharmaceuticals, Inc.

Welcome to Novo Nordisk in the U.S. | Novo Nordisk U.S. Website

Watertown, United States · Founded 2015 · $239.0M raised

Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$239.0M
Last Round
$3.0M GrantSep 2020
Rounds
9

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Dicerna Pharmaceuticals is a biopharmaceutical company and wholly owned subsidiary of Novo Nordisk, acquired in December 2021 for approximately $3.3 billion. Founded in 2007 and headquartered in Lexington, Massachusetts, Dicerna develops RNAi-based therapies using its proprietary GalXC platform. Pipeline spans rare diseases, cardiometabolic conditions, and neurodegenerative diseases.

Summary

Dicerna Pharmaceuticals, Inc. is a Biotech company based in Watertown, United States, founded in 2015. It has raised $239.0M in total across 9 rounds, most recently a $3.0M Grant round in Sep 2020. Investors include Domain Associates, RA Capital Management and SR One.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantSBIR Phase II (NIH)Sep 2020
$3.0M

Sign up to see all 9 events

Funding: Series A through Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Dicerna Pharmaceuticals, Inc. on Indexed.vc
<a href="https://indexed.vc/companies/dicerna-pharmaceuticals-inc"><img src="https://indexed.vc/api/badge/company/dicerna-pharmaceuticals-inc" alt="Dicerna Pharmaceuticals, Inc. on Indexed.vc" width="260" height="76" /></a>